APEMY – aperam new york registry (US:NASDAQ)

News

Aperam (APEMY) had its "neutral" rating reaffirmed by Citigroup Inc..
Aperam (APEMY) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Aperam (APEMY) was downgraded by Zacks Research from "strong-buy" to "hold".
Aperam (APEMY) was upgraded by Zacks Research from "hold" to "strong-buy".
Aperam (OTCMKTS:APEMY) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com